MEI Pharma, Inc. financial data

Symbol
MEIP on Nasdaq
Industry
Pharmaceutical Preparations
Location
11455 El Camino Real, Suite 250, San Diego, CA
State of incorporation
DE
Fiscal year end
June 30
Former names
MARSHALL EDWARDS INC (to 6/6/2012)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 672 % +12.3%
Debt-to-equity 30 % -82%
Return On Equity -111 % -227%
Return On Assets -85.2 % -361%
Operating Margin 22.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.66M shares 0%
Common Stock, Shares, Outstanding 6.66M shares 0%
Entity Public Float 28.7M USD -9.75%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 6.66M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 6.66M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 16.2M USD -55.5%
General and Administrative Expense 22M USD -31.8%
Costs and Expenses 49.1M USD -28.5%
Operating Income (Loss) -49.1M USD -234%
Nonoperating Income (Expense) 2.49M USD -43.8%
Net Income (Loss) Attributable to Parent -46.6M USD -213%
Earnings Per Share, Basic -6.99 USD/shares -213%
Earnings Per Share, Diluted -6.99 USD/shares -213%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.95M USD +106%
Cash, Cash Equivalents, and Short-term Investments 26.9M USD -67.3%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD
Assets, Current 27.7M USD -68.6%
Property, Plant and Equipment, Net 5K USD -99.6%
Operating Lease, Right-of-Use Asset 0 USD -100%
Assets 27.8M USD -72.6%
Accounts Payable, Current 976K USD -69.7%
Employee-related Liabilities, Current 1.39M USD -8.05%
Accrued Liabilities, Current 1.9M USD -55.8%
Liabilities, Current 2.87M USD -66.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.87M USD -85.6%
Retained Earnings (Accumulated Deficit) -396M USD -13.3%
Stockholders' Equity Attributable to Parent 24.9M USD -69.4%
Liabilities and Equity 27.8M USD -72.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.5M USD +38.1%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities 14.7M USD +196%
Common Stock, Shares Authorized 226M shares 0%
Common Stock, Shares, Issued 6.66M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Deferred Tax Assets, Valuation Allowance 69.9M USD -8.24%
Deferred Tax Assets, Gross 69.9M USD -8.24%
Operating Lease, Liability 0 USD -100%
Depreciation 86K USD -11.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 14.6M USD -13.7%
Property, Plant and Equipment, Gross 7K USD -99.7%
Operating Lease, Liability, Current 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.48M USD +29.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.91M USD -18.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.96M USD -24%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD +2.99%
Deferred Tax Assets, Operating Loss Carryforwards 45.7M USD +32.5%
Preferred Stock, Shares Issued 100K shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.72M USD +6.43%
Operating Lease, Payments 13M USD +470%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 368K USD +323%
Operating Leases, Future Minimum Payments Due 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%